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Background: Brucella ovis causes an infectious disease responsible for infertility and subsequent economic losses in
sheep production. The standard serological test to detect B. ovis infection in rams is the complement fixation test
(CFT), which has imperfect sensitivity and specificity in addition to technical drawbacks. Other available tests include
the indirect enzyme-linked immunosorbent assays (I-ELISA) but no I-ELISA kit has been fully evaluated.
The study aimed to compare an I-ELISA kit and the standard CFT. Our study was carried out on serum samples
from 4599 rams from the South of France where the disease is enzootic. A Bayesian approach was used to estimate
tests characteristics (diagnostic sensitivity, Se and diagnostic specificity, Sp). The tests were then studied together
in order to optimise testing strategies to detect B. ovis.
Results: After optimising the cut-off values in order to avoid doubtful results without deteriorating the
concordance between the results of the two tests, the I-ELISA appeared to be slightly more sensitive than CFT
(Se I-ELISA = 0.917 [0.822; 0.992], 95% Credibility Interval (CrI) compared to Se CFT = 0.860 [0.740; 0.967], 95% CrI).
However, CFT was slightly more specific than I-ELISA (Sp CFT = 0.988 [0.947; 1.0], 95% CrI) compared to
Sp I-ELISA =0.952 [0.901; 1.0], 95% CrI).
The tests were then associated with two different interpretation schemes. The series association increased the
specificity of screening and could be used for pre-movement testing in rams from uninfected flocks. The parallel
association increased sequence sensitivity, thus appearing more suitable for eradicating the disease in infected
flocks.
Conclusions: The high sensitivity and acceptable specificity of this I-ELISA kit support its potential interest to avoid
the limitations of CFT. The two tests could also be used together or combined with other diagnostic methods such
as semen culture to improve the testing strategy. The choice of test sequence and interpretation criteria depends
on the epidemiological context, screening objectives and the financial and practical constraints.
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Brucella ovis is a Gram-negative coccobacillus. In sheep,
B. ovis infection is responsible for a reproductive disease,
often causing genital lesions such as unilateral or bilat-
eral epididymitis in rams and, more rarely, abortion
in ewes. This disease mainly spreads via venereal trans-
mission, even though other routes of infection have
been observed. Infected ewes generally clear the micro-* Correspondence: bruno.garin-bastuji@anses.fr
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reproduction in any medium, provided the ororganism from the vagina within two oestrus cycles
[1], but the clearance period can extend up to three
months [2]. It has also been suggested that ewes could
play a role in the maintenance of the infection in flocks
[3,4].
B. ovis infection in sheep was first reported in 1953 in
Australia and New Zealand [5]. It is currently present in
South and North American countries, Australia, New-
Zealand, South Africa and Southern European countries
[6]. In France, the number of infected flocks has
increased since Rev.1 vaccination against B. melitensis
infection was stopped in 2008.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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flocks (decrease in fertility, ban on trade). These losses
must be taken into account when evaluating the most
suitable screening strategy. Financial losses are princi-
pally due to a drop in fertility, with recycling ewes com-
monly observed in an infected flock. Reproductive
failure rates depend on the extent of lesions: if only one
testicle is involved, conception rates may be 70%,
whereas in healthy rams conception rates of 90% can be
expected [7]. Estimates of the abortion rate in ewes and
perinatal mortality vary from 0% to 8% in experimental
studies. Furthermore, lambs born in the second and
third cycle are 10–20 lbs lighter at weaning which can
equate to a loss of $10 to $20 for each cycle missed [7].
B. ovis infection also induces indirect losses such as a
shorter reproductive career, a decrease in the economic
value of rams or an increase in the number of rams
needed per ewe [8]. These observations emphasise the
importance of developing suitable testing strategies in
various control and eradication situations.
The diagnosis of B. ovis infection mainly depends on
serological tests. The clinical detection of the disease is
difficult because other bacteria, such as Actinobacillus
seminis, Histophilus ovis, Haemophilus spp., Corynebac-
terium pseudotuberculosis ovis, Chlamydophila abortus
or B. melitensis, may cause similar symptoms and more
than 50% of B. ovis infected animals do not show any
palpable epididymitis lesion [9]. Infected rams excrete B.
ovis in semen intermittently, so the bacteriological
examination of semen is not very sensitive [10].
As in many other parts of the world, there is currently
no compulsory surveillance of the disease in EU flocks.
Moreover, neither compulsory eradication programme
nor compensation scheme for culling animals in
infected flocks is foreseen in the EU Member States.
Nevertheless, in order to avoid the contamination of
non-infected areas or flocks through international or
intra-community trade, rams have to undergo sero-
logical pre-movement tests [11]. Rams are also tested
before their admission to artificial insemination units.
On farms, diagnosis mainly relies on a clinical detection
and a serological test when the palpation of testicles
reveals lesions or when there is significant infertility in
the flock.
Various tests are available to detect B. ovis antibodies
in serum, such as the complement fixation test (CFT),
agar gel immunodiffusion (AGID) or indirect enzyme-
linked immunosorbent assay (I-ELISA) but only CFT
is prescribed for international or intra-community
trade ([6,12]). CFT has good sensitivity and specificity
but also has some technical drawbacks such as anti-
complementary activity [13], prozone phenomenon [14],
incompatibility with haemolysed sera ([10,14]), serum in-
activation [14] and workload [15].Other tests such as the indirect ELISAs (I-ELISA) are
available but no I-ELISA kit has been fully evaluated in
previous studies. According to literature data, some I-
ELISAs appear more sensitive than CFT ([12,16]), but
there are differences in the contexts (various geograph-
ical areas, breeds and breeding conditions of the ani-
mals, sample sizes, tests manufacturers and cut-off
values) and the statistical methods used for comparison
(CFT being considered as the gold standard and estima-
tion of relative sensitivity and specificity of I-ELISA)
([15-19]). Advantages of I-ELISA include its ease of use;
it is less labour intensive than CFT and can be used to
test haemolysed or anti-complementary serum samples
[15].
Our study compared a commercial I-ELISA kit and
standard CFT in order to evaluate its potential use as a
complementary test for international trade or for diag-
nosis on farms, and to assess its possible use instead of
CFT or in association with it to improve the detection




The study included sera from 4,599 rams collected in
the South of France, in areas where B. ovis infection is
enzootic: 3,063 were from Pyrénées Atlantiques (subpo-
pulation 1; individual prevalence estimated at 22% in
2006 [20]), 1,340 were from Provence-Alpes-Côte d’Azur
(subpopulation 2; enzootic infection but prevalence un-
known) and 196 young rams, between 12 and 14 months
of age, were from a cooperative that was found to be
infected, B. ovis being isolated in some animals (subpo-
pulation 3). A free population used as a source of prior
information on the specificity of I-ELISA included 3,792
rams selected from free artificial insemination (AI) units.
Blood samples were collected as part of the usual offi-
cial screening scheme on farms (and not specifically for
research) The EU recommendations about screening
procedures and EU ethical guidelines and animal welfare
regulations were strictly respected.
Serological tests
CFT and I-ELISA (Chekit B. ovis, Idexx, France) were
performed in parallel on all sera from the infected popu-
lations described above. The antigens used for both CFT
and I-ELISA consisted in a hot-saline water soluble ex-
tract of the REO 198 strain prepared according to OIE
recommendations [4]. The CFT antigen (ANSES, France)
was standardized against the International Standard
anti-Brucella ovis Serum (ISaBoS; AHVLA, UK) and the
test performed according to OIE and EU requirements
with a positivity threshold of 50 ICFTU/mL ([6,11]). I-
ELISA included an anti-ruminant IgG monoclonal
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gate, 3,3′,5,5′-Tetramethylbenzidine (TMB) as substrate
and a slightly acidic detergent solution as stopping re-
agent. Serum samples and conjugate incubation steps
were performed at 37 °C for 60 min. (± 10 min.). Sub-
strate was incubated at room temperature for 15 min.
Optical densities (450 nm) were then transformed in %
values by comparing the test-sample optical density
(OD) to the positive control OD, both ODs being cor-
rected by subtracting the negative control OD. The
manufacturer’s recommended cut-offs were negative if
under 10%, doubtful between 10% and 50% and positive
above 50%. The reproducibility of each batch used in the
study was checked against the ISaBoS on two plates per
batch. All tests were performed by the same two techni-
cians at the EU/OIE/FAO Brucellosis Reference Labora-
tory (ANSES, Maisons-Alfort, France). The blood
samples were collected in the frame of a national official
surveillance program. All samples were provided to the
authors’ laboratory either by the local breeders’ organi-
zations (GDS) or by the National Laboratory for the
Control of Breeding Animals without any Material
Transfer Agreement. Therefore these blood samples
could be freely used for the production of any additional
data.Table 1 Parameters of the Beta(a,b) distributions used as
priors





CFT Se* 0.9 0.8 31.5 3.5
Sp* 0.95 0.8 7.07 0.37
I-ELISA Se* Unknown Unknown 1 1
Sp* 0.98 0.9 11.03 0.23
Prevalence γ Se* Unknown Unknown 1 1
γ Se* Unknown Unknown 1 1
Unknown Unknown 1 1
*Se = Sensitivity; Sp = Specificity; γ= covariance.Data analyses
A new cut-off was established (see additional details in
the Results section) to eliminate doubtful results without
deteriorating the concordance between the results of
CFT (the officially prescribed test) and I-ELISA.
Then, each test’s sensitivity (Se) and specificity (Sp)
were estimated using a Bayesian approach implemented
through Markov Chain Monte Carlo algorithms. The
Bayesian approach has often been used to estimate sen-
sitivities and specificities of tests in the absence of a gold
standard, whether in veterinary or human medicine
([21-23]). The main advantage of this method is to com-
bine prior information from the literature and experts’
advice with field data.
The model used was a generalization of the Bayesian
independence model to allow for dependent test out-
comes. It has been applied in previous studies ([21,24-
26]) and used to estimate the respective covariance of
the sensitivities (γSe) and of the specificities of the two
tests (γSp). Two tests are said to be independent of,
given that an animal is diseased (or not), the probability
of positive (or negative) outcome for the first test is the
same whatever the outcome for the other test [27]. Both
tests are based on the same biological process: they use
the same HS antigen preparation and therefore detect
mainly anti-Brucella-R-LPS antibodies. They are conse-
quently expected to be conditionally dependent [24].Prior distributions of parameters were modelled as
beta distributions ([27,28]). To construct a beta prior
distribution, the most probable value of the parameter
(or “best guess”; θ0) and a “lower limit” (θL; i.e. a value
for which the experimenter is 95% sure that the param-
eter will be larger) were determined [27]. Table 1 pro-
vides the parameters of the beta (a,b) distribution for
each parameter estimated by the model.
Prior information on CFT combined literature and
experts’ advice with field data. Only prior information
from similar studies in literature was input into the
model. According to previous studies, mean CFT sensi-
tivity ranged from 88.9% to 98.7% and mean CFT specifi-
city from 89.3% to 100%. The lowest sensitivity reported
was 77% and the lowest specificity 78% ([10,14,29-33]).
Prior information on I-ELISA specificity (Sp I-ELISA)
was input from a study performed on the sera from the
3,792 rams selected in officially brucellosis free AI units.
As these rams were being raised in specific conditions,
with little contact with environmental pathogens poten-
tially responsible for cross-reactions, they were not rep-
resentative of the population bred on farms in the South
of France. They were not therefore studied with the
population of 4,599 rams from the South of France but
used to provide prior information on the specificity of I-
ELISA (Sp I-ELISA= 99.74%).
Since little information was available in the literature
on this I-ELISA sensitivity and since the corresponding
studies were carried out with very different methods, in
different contexts, as indicated above, beta (1,1) unin-
formative distributions (uniform distributions between 0
and 1) were chosen.
Prevalence in the population and covariance of the
sensitivity and the specificity were unknown: beta (1,1)
uninformative distributions were also used as priors for
these parameters.
The statistical analysis was performed with the Win-
BUGS program [34]. The MCMC algorithm convergence
was assessed by checking the stabilisation of the plots of
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and by running multiple chains from dispersed starting
values. Early samples (1,000 out of 50,000) were dis-
carded as a “burn-in” period. A sensitivity analysis was
also performed by making the prior distributions more
diffuse in order to check that the parameter estimates
were little affected by these variations [27].
After having estimated the sensitivity and the specifi-
city of the two tests, their characteristics were evaluated
when used in association [35]. With the serial associ-
ation, the overall result was positive when the results
were positive with both tests. With the parallel associ-
ation, the overall result was positive when at least one
test gave a positive result. The sensitivity and specificity
of the combined tests were estimated taking into ac-
count the conditional dependence between results [24].
The sensitivity of the serial association was: SeSERIES =
SeIELISA*SeCFT + γSe and its specificity was: SpSERIES = (1
- SpIELISA)*(1 – SpCFT) – γSp. The sensitivity of the asso-
ciation in parallel was: SePARALLEL = 1-((1-SeIELISA)*(1-
SeCFT)) – γ Se and its specificity was: SpPARALLEL = SpIE-
LISA * SpCFT + γ Sp; (with Se: sensitivity, Sp: specificity, γ:
covariance).Results
A new cut-off was established for I-ELISA in order to
eliminate doubtful results without affecting the concord-
ance between the results of CFT (the officially pre-
scribed test) and I-ELISA. A cut-off at 45% OD (see
above) was the best compromise to optimise both the
concordance of positive results and the concordance of
negative results. With this new cut-off, the two tests
gave concordant results (positive / positive or negative /
negative) for 4,161 rams (92.6%).
The apparent prevalence assessed in the whole studied
population by the I-ELISA kit was 25.6%. In the subpo-
pulations 1, 2 and 3, the apparent prevalences were re-
spectively 17.0%, 44.8% and 27.6%. Table 2 gives the
results of the 4,599 tested rams.
The I-ELISA kit was slightly more sensitive than the
CFT (Se I-ELISA= 0.917 [0.822; 0.992], 95% Credibility
Interval (CrI) whereas Se CFT= 0.860 [0.740; 0.967],Table 2 Cross-classified results in 4,599 rams from the
South of France
CFT I-ELISA* Number of rams
(proportion)
Negative Negative 3,335 (72.8%)
Negative Positive 270 (5.9%)
Positive Negative 72 (1.6%)
Positive Positive 902 (19.7%)
TOTAL 4,599 (100%)
* cut-off: 45% OD.95% CrI). In contrast, the CFT was somewhat more spe-
cific than the I-ELISA (Sp CFT= 0.988 [0.947; 1.0], 95%
CrI whereas Sp I-ELISA= 0.952 [0.901; 1.0], 95% CrI).
Prevalence in the studied population of 4,599 from the
South of France was evaluated at 0.238 ([0.187; 0.284],
95% CrI). The sensitivity covariance was 0.0241
([−0.00773; 0.0949], 95% CrI) and the specificity covari-
ance was 0.00521 ([−4.61 10-7; 0.0361], 95% CrI).
These two tests could also be associated to improve
diagnosis reliability. Two interpretation schemes were
studied: a serial association and a parallel association.
The estimations of sensitivity and specificity of each se-
quence were based on the individual sensitivities and
specificities described above.
The diagnostic sensitivity of the association in series
was SeSERIES = 0.812 [0.699; 0.980] (95% CrI) and its spe-
cificity was SpSERIES = 0.995 [0.994; 0.996] (95% CrI). The
diagnostic sensitivity of the parallel association was
SePARALLEL = 0.964 ([0.902; 0.983], 95% CrI) and its spe-
cificity was SpPARALLEL = 0.946 ([0.854; 1.0], 95% CrI).
Discussion
The estimation of the mean prevalence in the sample
(24%) confirmed the value assessed previously in French
areas in which B. ovis infection is enzootic [20].
The estimation of the diagnostic sensitivity and specifi-
city of a test should ideally be derived from testing a sta-
tistically relevant panel of animals. The history of these
animals and their infection status should be known. The
panel should be representative of the region where the
test is to be used [36]. As mentioned above, there is cur-
rently no regulatory program in the EU for eradicating
the disease or surveying the absence of B. ovis infection
(i.e. with an appropriate definition of a B. ovis-free sta-
tus), except in AI units. In these units, animals are kept
in specific conditions that could lead to an overesti-
mation of tests specificity. Designing an adequate sam-
pling of a sufficient number of free animals (from free
flocks) is therefore very difficult. Moreover, the selection
of an appropriate gold-standard-infected population (i.e.
culture-positive animals) is extremely cumbersome and
requires a very important budget Furthermore, Brucella-
culture should be performed in conditions providing
optimised sensitivity, with a corresponding increase in
costs, in order to prevent any consecutive overesti-
mation of the diagnostic sensitivity of the serological
tests under study. The technical and financial constraints
highlighted above justify the use of the Bayesian ap-
proach to estimate the characteristics of serological tests
for the diagnosis of B. ovis infection when the infection
status of each animal of the studied population is
unknown.
The outcome of our study is consistent with previous
results available in the literature. The CFT has a good
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has some technical disadvantages. The EU/OIE/FAO
Reference laboratory estimated that this I-ELISA com-
mercial kit was cheaper than the CFT (in-house pro-
duced antigen) when the cost was calculated for a daily
analysis of 90 serum samples, mainly due to lower man-
power costs (data not shown). Moreover, the evaluated
I-ELISA is standardised and easier and quicker to per-
form. Altogether, these advantages allow the analysis of
more samples by a single technician in a working day
than the CFT. Moreover, the I-ELISA can be automated
to speed up the process. Furthermore, haemolysed and
anti-complementary sera do not affect I-ELISA perform-
ance ([15,32]). These advantages may further reduce the
cost of this I-ELISA compared to the CFT.
In a screening situation, one important issue is the in-
terpretation of doubtful results obtained with the I-
ELISA. We established a cut-off different from that
recommended by the manufacturer to avoid doubtful
results without decreasing the concordance between the
results of the two tests. Nevertheless, it is possible to ad-
just this cut-off according to the epidemiological con-
text. When the test is used for international or intra-
community trade, false positive results due to a lack of
specificity could hinder trade and raise economic issues
in brucellosis free contexts. Exported rams should come
exclusively from uninfected farms (i.e. showing only
negative results to regular tests), so the positive predict-
ive value of the test results is low. For this reason, a high
cut-off value could be used (for instance 60% OD). In
contrast, when the test is used to diagnose B. ovis infec-
tion in infected areas or to confirm the infection in rams
with clinical lesions with the aim of eradicating the dis-
ease, false negative results might slow down eradication
and, in particular conditions, it could be acceptable to
cull seropositive but uninfected rams. Accordingly, in a
context of high prevalence, a low cut-off value could
therefore be used (for example 30% OD).
The imperfect diagnostic performance of both tests
could justify their use in association [35]. With the serial
association, the overall result is positive when the results
are positive with both tests. This interpretation scheme
increases the diagnostic specificity of screening and
could therefore be recommended for pre-movement
testing in a brucellosis free context, in order to avoid
false positive results due to the relative lack of diagnostic
specificity of this I-ELISA. With the parallel association,
the overall result is positive when at least one test gives
a positive result.
The parallel association increases the sensitivity of
the screening. Accordingly, it could be recommended in
a context of suspected infection with the aim of acceler-
ating the eradication of the disease. In this context,
many sera may have to be tested in a flock and therapidity of the process influences the success eradica-
tion operations.
The following situations would be suitable for applica-
tion of screening strategies using the I-ELISA kit:
– Rams for export must come from brucellosis free
flocks. In this case, the animals could be tested with
I-ELISA alone. If all results were negative, rams
could be qualified for export. Rams from flocks
showing positive results to I-ELISA should not be
exported and should be subjected to further
investigations (clinical examination, CFT, semen
culture or PCR for instance) to confirm or rule out
the infection.
– In infected flocks in which B. ovis has already been
identified, the testing regime should be focused on a
quickly eradication of the disease. In this case, all
animals (including females) should be submitted to
I-ELISA and CFT in parallel. Animals with positive
results to at least one of the two tests should be
culled and replaced by virgin animals from flocks
free of B. ovis infection. The remaining animals
resulting negative to both tests could be kept in the
flock but should neither be sold nor exported.
Further tests should be carried out at 45- to 60-days
intervals until all infected animals have been
eliminated (i.e. after the entire animal population
has been tested negative twice). This strategy raises
financial issues in infected flocks with a high
prevalence of the disease, because many animals
would be culled.
– In all flocks, animals should be submitted to a
clinical examination two months before the breeding
season. Rams with clinical signs of epididymitis
should be banned from reproduction and subjected
to an I-ELISA test. Rams with positive results to I-
ELISA should undergo further investigations (semen
culture) to confirm the presence of Brucella ovis.
Conclusions
Our study used a Bayesian approach to evaluate the
diagnostic performance of a commercially available I-
ELISA kit to detect B. ovis infection in sheep. We
showed that this I-ELISA kit was slightly more sensitive
than the CFT, but somewhat less specific. The high sen-
sitivity and acceptable specificity of the I-ELISA kit sup-
port its potential interest for diagnosing B. ovis infection
in sheep. This I-ELISA kit has certain advantages over
CFT and could be used alone or as a first test in asso-
ciated testing regimes. The interpretation of the results
and the testing sequences should be chosen depending
on screening objectives, the disease’s prevalence in the
target population and economic and practical
constraints.
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